<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="factor_count">1</item><item key="sample_count">2</item><item key="tags"><item>genome</item><item>nucleotide</item><item>peripheral</item><item>syndrome</item></item><item key="slug">a-whole-genome-approach-to-characterising-a-novel</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-14845</item><item key="id">3171</item><item key="species">human</item><item key="name">A Whole Genome Approach to Characterising a Novel Immunodeficiency Disorder</item></item><item><item key="factor_count">1</item><item key="sample_count">10</item><item key="tags"><item>adenoma</item><item>carcinoma</item><item>genome</item><item>serous carcinoma</item></item><item key="slug">braf-mutation-is-rare-in-advanced-stage-low-grade</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-27659</item><item key="id">3983</item><item key="species">human</item><item key="name">BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas</item></item><item><item key="factor_count">2</item><item key="sample_count">30</item><item key="tags"><item>cancer</item><item>cell</item><item>genome</item><item>line</item><item>membrane</item><item>point</item><item>protein</item><item>serum</item></item><item key="slug">canonical-nf-kb-activation-is-essential-for-epstei</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-29297</item><item key="id">4085</item><item key="species">human</item><item key="name">Canonical NF-kB Activation is Essential for Epstein-Barr Virus Latent Membrane Protein 1 TES2/CTAR2 Gene Regulation.</item></item><item><item key="factor_count">2</item><item key="sample_count">120</item><item key="tags"><item>class</item><item>genome</item><item>spindle</item></item><item key="slug">characterization-of-formaldehydes-genotoxic-mode-o</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-41296</item><item key="id">2439</item><item key="species">human</item><item key="name">Characterization of Formaldehyde's Genotoxic Mode of Action by Gene Expression Analysis in TK6 Cells</item></item><item><item key="factor_count">0</item><item key="sample_count">9</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>chromatin</item><item>disease</item><item>estrogen</item><item>genome</item></item><item key="slug">chromatin-immunoprecipitation-profiling-of-human-b</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-11506</item><item key="id">2877</item><item key="species">human</item><item key="name">Chromatin immunoprecipitation profiling of human breast cancer cell lines and tissues to identify novel estrogen receptor-{alpha} binding sites and estradiol target genes</item></item><item><item key="factor_count">6</item><item key="sample_count">15</item><item key="tags"><item>disease</item><item>epilepsy</item><item>genome</item><item>juvenile neuronal ceroid lipofuscinosis</item><item>neuronal ceroid lipofuscinosis</item></item><item key="slug">cln3-patients-with-differing-progression-of-the-di</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-22225</item><item key="id">3687</item><item key="species">human</item><item key="name">CLN3 patients with differing progression of the disease</item></item><item><item key="factor_count">4</item><item key="sample_count">7</item><item key="tags"><item>bone</item><item>bone marrow</item><item>cell</item><item>fibronectin</item><item>genome</item><item>interleukin</item><item>interleukin-6</item><item>multiple myeloma</item><item>myeloma</item><item>syndecan</item></item><item key="slug">comparison-of-bone-marrow-mesenchymal-stromal-cell</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-36474</item><item key="id">2500</item><item key="species">human</item><item key="name">Comparison of bone-marrow mesenchymal stromal cells from multiple myeloma patients and healthy donors</item></item><item><item key="factor_count">0</item><item key="sample_count">15</item><item key="tags"><item>genome</item><item>middle</item></item><item key="slug">comparison-of-endometrial-expression-in-patients-w</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-26787</item><item key="id">3934</item><item key="species">human</item><item key="name">Comparison of endometrial expression in patients which underwent previous recurrent abortions, implantation failure after IVF/ICSI compared to control fertile</item></item><item><item key="factor_count">0</item><item key="sample_count">19</item><item key="tags"><item>disease</item><item>genome</item><item>intracranial aneurysm</item><item>leukocyte</item><item>median</item><item>stroke</item></item><item key="slug">comparison-of-gene-expression-between-ruptured-and</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-13353</item><item key="id">3069</item><item key="species">human</item><item key="name">Comparison of gene expression between ruptured and unruptured human intracranial aneurysms</item></item><item><item key="factor_count">2</item><item key="sample_count">9</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>colon</item><item>colon cancer</item><item>disease</item><item>genome</item><item>protein</item></item><item key="slug">comparison-of-gene-expression-profiles-of-ht29-cel</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-35382</item><item key="id">2425</item><item key="species">human</item><item key="name">Comparison of gene expression profiles of HT29 cells treated with Instant Caffeinated Coffee or Caffeic Acid versus control.</item></item></data></biogps>
